ARANEUS BIO Trademark

Trademark Overview


On Friday, March 15, 2024, a trademark application was filed for ARANEUS BIO with the United States Patent and Trademark Office. The USPTO has given the ARANEUS BIO trademark a serial number of 98451015. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 26, 2024. This trademark is owned by Araneus Bio, Inc.. The ARANEUS BIO trademark is filed in the Pharmaceutical Products category with the following description:

Hydrogels for medical purposes; Hydrogels featuring pharmaceuticals; Chemoimmunotherapy; Pharmaceuticals
araneus bio

General Information


Serial Number98451015
Word MarkARANEUS BIO
Filing DateFriday, March 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHydrogels for medical purposes; Hydrogels featuring pharmaceuticals; Chemoimmunotherapy; Pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAraneus Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Sunday, March 17, 2024NEW APPLICATION ENTERED
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 25, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED